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Abstract
Objective 
Whole exome sequencing (WES) is a new molecular diagnostic 
test, used in pediatric medicine, especially pediatric neurology. 
The diagnostic yield of WES is higher than conventional methods. 
Therefore, this study aimed to assess the diagnostic yield of WES in a 
pediatric neurology clinic and to report positive results.
Materials & Methods
This retrospective study was performed on patients, presenting to 
the pediatric neurology clinic of Ghaem Hospital in Mashhad, Iran, 
between March 2015 and March 2017, with various neurological 
disabilities and unrevealing workup before WES. The patients’ 
clinical features and molecular diagnoses based on the WES results 
were reported in this study.
Results
The overall diagnostic yield of WES was 82.71% (67/81 patients). 
Two patients were excluded for the lack of data. Sixty-five patients 
with pathogenic or possibly pathogenic variants exhibited various 
abnormalities, including intellectual disability/developmental delay 
(n=44), seizure (n=27), developmental regression (n=11), myopathy 
(n=9), microcephaly (n=8), neuropathy (n=2), autism spectrum 
disorder (n=2), and neuromuscular disease (n=2). Overall, 93.84% of 
the patients were born to consanguineous parents. Also, 62 patients had 
an autosomal recessive disorder, and three patients had an autosomal 
dominant disorder.
Conclusion 
The present findings indicating the high diagnostic yield of WES, 
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Introduction
The causes of neurodevelopmental disorders 
are not identified in many patients (1). Accurate 
genetic diagnosis can improve the patient’s health 
by identifying, starting, or changing the existing 
treatments (2). Current diagnostic approaches, 
including clinical assessments, laboratory tests, 
chromosomal microarrays, single gene sequencing, 
and gene panel sequencing, are effective in 46% 
of patients in pediatric clinics (3). Also, these 
approaches are diagnostic in 25% of patients with 
neurodevelopmental disorders (2).
Whole exome sequencing (WES) is a new 
molecular diagnostic test, with a higher diagnostic 
yield than conventional methods (2). The diagnostic 
yield of WES is variable in heterogeneous groups 
of patients (2, 4). In previous studies evaluating 
heterogeneous groups of pediatric neurology 
patients, the diagnostic yield of WES was estimated 
at 49.1%, 41%, and 19%, respectively (5-7). 
Therefore, the present study aimed to assess the 
diagnostic yield of WES in our pediatric neurology 
clinic and to report positive results between March 
2015 and March 2017.
Materials & Methods
In this retrospective study, we evaluated the medical 
records of patients, who presented to the pediatric 
neurology clinic of Ghaem Hospital in Mashhad, 
besides the important role of this test in determining the etiology of 
non-specific and atypical presentations of genetic disorders, support 
the use of WES in pediatric neurology practice.
Keywords: Whole exome sequencing; Diagnostic yield; Pediatric 
neurology
DOI:10.22037/ijcn.v15i2.26401
Iran between March 2015 and March 2017 and 
underwent WES. WES was ordered by pediatric 
neurologists when genetic causes were suspected 
based on their clinical judgment. We extracted 
and analyzed the patients’ data, including age, 
sex, disease phenotype, family history, affected 
siblings, parental consanguinity, and gene variants. 
However, we excluded patients with insufficient 
medical records.
All families completed a written informed 
consent form before WES. This study was 
approved by the Ethics Committee of Mashhad 
University of Medical Sciences (code: IR.MUMS.
fm.REC.1396.390).
Results
WES was performed on DNA of 81 patients, 
presenting to the pediatric neurology clinic of 
Ghaem Hospital in Mashhad, Iran between March 
2015 and March 2017. An unknown genetic 
disorder was suspected in all patients before 
WES. Diagnostic evaluations, such as clinical 
assessments, biochemical and metabolic tests, 
imaging tests, biopsy, and genetic tests (i.e., 
karyotyping, chromosomal microarray, and single 
gene sequencing), had been carried out prior to 
WES for the majority of patients. 
Genomic DNA was extracted from the peripheral 
blood samples using standard methods and sent 
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to laboratories for WES. The result of WES was 
approved by the pediatric neurologist who had 
visited the patient. A proven or hypothesized 
molecular effect related to the patient’s phenotype 
was required in the genetic variant; also, the variant 
should follow the Mendelian inheritance model, 
consistent with the status of each affected family 
member. All results were confirmed via Sanger 
sequencing.
The overall diagnostic yield of WES was estimated 
at 82.71% (67/81 patients); therefore, 67 patients 
had pathogenic or possibly pathogenic variants. 
Two patients were excluded for the lack of data. 
Full clinical and molecular data of all 65 patients 
are presented in Table 1. Of 65 eligible patients, 39 
(60%) were male, and 26 (40%) were female, with 
the mean age of 8.125.15± years.
Sixty-five patients with pathogenic or 
possibly pathogenic variants exhibited various 
abnormalities, including intellectual disability/
developmental delay (n=44), seizure (n=27), 
developmental regression (n=11), myopathy (n=9), 
microcephaly (n=8), neuropathy (n=2), autism 
spectrum disorder (n=2), and neuromuscular 
diseases (n=2). Moreover, of 65 eligible patients, 
61 (93.84%) were born to consanguineous parents: 
first cousins, 48 (78.69%); second cousins, 6 
(9.83%); and double cousins, 1 (1.64%). Forty-
three (66.2%) out of 65 eligible patients had an 
affected sibling with a similar phenotype, although 
its severity varied.
Of 65 patients with a genetic diagnosis, 62 
(95.39%) had an autosomal recessive disorder, and 
3 (4.61%) had an autosomal dominant disorder. 
The variant types in 65 patients with a genetic 
diagnosis were missense (n=34), nonsense (n=12), 
frameshift (n=11), splice site (n=5), deletion (n=2), 
and insertion (n=1).
20
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Discussion
The diagnostic yield of WES in the present 
study was remarkably high for 81 previously 
undiagnosed pediatric neurology patients, with a 
success rate of 82.71%. In heterogeneous pediatric 
neurology cohorts, the diagnostic yield of WES 
varies substantially. In this regard, a study on 78 
children with undiagnosed neurological diseases 
showed that the diagnostic yield of WES was 
41% (6). Moreover, in a neurogenetic clinic, the 
diagnostic yield of WES was 49% among 57 
patients with various undiagnosed neurological 
diseases (5). Also, in a WES study of 118 patients 
with neurodevelopmental disorders, for whom 
conventional genetic tests were undiagnostic, 8% 
of cases had a mutation in known genes causing 
diseases, and 19% had a mutation in novel genes 
possibly causing diseases (7). 
In a previous study evaluating 47 genetic centers, the 
success rate of WES was estimated at 22.8% (13). 
The diagnostic yield of WES was 25% in a study 
on 250 probands, who were referred from genetic, 
pediatric, and neurology clinics (14). Moreover, in 
a study on patients with neuromuscular diseases, 
associated with the parents’ consanguineous 
marriage, the diagnostic yield of WES was 73.3% 
(3). The high diagnostic yield of WES in the present 
study, where 93.4% of the patients were born to 
consanguineous parents, could be attributed to our 
patient population, as WES was performed for 
those with highly suspected genetic factors.
As shown in Table 1, the same variant of TMEM67 
gene was found in two patients (case 1 and case 
46). The clinical and imaging findings suggested 
Joubert syndrome in case 1, whereas in case 46, 
developmental delay, behavioral disorder, and 
amblyopia were found, which are not the usual 
diagnostic signs of this disease. These findings 
indicate that WES can be utilized for identifying 
the unusual manifestations of rare diseases. 
Eight different mutations have been found in 
Plexin B1 (PLXNB1) gene, five of which are 
considered pathogenic, and one is considered 
to be possibly pathogenic. However, there is not 
sufficient evidence to identify the phenotypes of 
these mutations (15). In the present study, we found 
the same mutation in two related patients with 
the central nervous system (CNS) involvement; 
however, their phenotypes were different (case 40 
and case 41 in Table 1).
A mutation in the abnormal spindle-like 
microcephaly associated (ASPM) gene is the most 
common cause of genetic microcephaly. More than 
100 mutations in this gene have been identified 
so far (16). We found two different variants of 
ASPM gene in two patients. The c.9697C>T 
(p.Arg3233Ter) variant was identified as a disease-
causing variant (17), whereas the c.2650_2651insG 
(p.Lys884Argfs*15) variant was a novel mutation 
in our study.
In the present study, case 25 was one of the four 
patients, who had the same clinical manifestations 
and different mutations in the PPP1R21 gene. 
This patient had been evaluated for developmental 
delay since the age of eight months, and a thin 
cerebral cortex, especially in the frontotemporal 
regions, large lateral ventricles, thinning of the 
corpus callosum, and atrophy/hypoplasia of the 
optic nerve were detected in the brain MRI. The 
function of protein, translated from the PPP1R21 
gene, was not definitely identified. However, based 
on previous studies, its deletion causes a specific 
neurodevelopmental syndrome with symptoms of 
mild endosomal/lysosomal dysfunction (9).
In routine clinical practice, indications for WES 
are not as complicated as the interpretation of its 
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results. Determination of the patient’s phenotype is 
the first step in requesting WES. If the phenotype 
is compatible with a known syndrome, the next 
step is ordering conventional targeted genetic tests 
for evaluations. Based on the American College of 
Medical Genetics and Genomics (ACMG), WES 
should be performed for the following patients: (1) 
patients with a suspected genetic disorder, whose 
phenotype is not compatible with the suspected 
syndromes; (2) patients with clinical manifestations 
which have various genetic causes; and (3) patients 
without an acceptable cause for the phenotype (18). 
In this study, WES was requested after the routine 
diagnostic tests yielded unsuccessful results, 
while according to recent studies, it is more cost-
effective if clinicians request WES for patients 
with a suspected genetic disorder in the primary 
visits (2, 9, 15, 19).
Despite the high diagnostic yield of WES, this test 
has several limitations. WES cannot identify large 
insertions and deletions, structural chromosomal 
rearrangements, trinucleotide repeats, epigenetic 
modifications, or mutations in non-exon regulatory 
regions. There are also technical limitations in 
sequencing mitochondrial DNA (5, 6, 20). Also, 
uncertainty about the function of possible genetic 
findings is another limitation of WES, which can lead 
to the misidentification of genes and misdiagnosis 
(5, 6). On the other hand, the neurodevelopmental 
phenotype of a patient is affected by many 
factors, such as complicated interactions between 
various genes and environmental factors. Due to 
the unavailability of WES in Iran, in the present 
study, the extracted DNAs were sent abroad 
for sequencing; therefore, establishing the final 
diagnosis can be time-consuming.
In conclusion
The diagnostic rate of WES was remarkably high 
in our pediatric neurology clinic, with a success 
rate of 82.71%. Considering the high diagnostic 
yield of WES, its application in prenatal care can 
expand the genetic knowledgebase; therefore, 
clinicians should consider requesting WES in their 
routine practice.
Acknowledgement 
We appreciated all patients who participated in this 
study, and would like to thank of all technicians in 
genetic lab for doing tests and had very cooperation 
with children during sampling.
Author’s Contribution
Negin AHMADNIA: Carried out the research and 
wrote the article.
Mehran BEIRAGHI TOOSI: Literature review and 
referred patients 
Ehsan GHAYOUR KARIMIANI: Conceptualized 
the study, did the collection of data and reviewed 
articles. 
Mohammad FARAJIRAD: Helped in literature 
review, and approved the final manuscript as 
submitted.
Farah ASHRAFZADEH: Conceptualized the 
study, reviewed articles and writing article 
All authors agreed to be accountable for all aspects 
of the work in ensuring that questions related to the 
accuracy or integrity of any part of the work are 
appropriately investigated and resolved.
Conflict of Interest 
This study was carried out with no specific grant 
or funding. This article has not been previously 
published and/or presented as a poster or an oral 
presentation in any other national or international 
30
The Results of Whole Exome Sequencing Performed On Previously Undiagnosed Pediatric Neurology Patients
Iran J Child Neurol. Spring 2021 Vol. 15 No. 2
meeting. All authors declare that there is no conflict 
of interest.
References
1. Gropman AL, Batshaw ML. Epigenetics, 
copy number variation, and other molecular 
mechanisms underlying neurodevelopmental 
disabilities: new insights and diagnostic 
approaches. Journal of Developmental & 
Behavioral Pediatrics. 2010;31(7):582-91.
2. Fogel BL, Satya-Murti S, Cohen BH. Clinical 
exome sequencing in neurologic disease. 
Neurology: Clinical Practice. 2016;6(2):164-
76.
3. Shashi V, McConkie-Rosell A, Rosell B, Schoch 
K, Vellore K, McDonald M, et al. The utility 
of the traditional medical genetics diagnostic 
evaluation in the context of next-generation 
sequencing for undiagnosed genetic disorders. 
Genetics in Medicine. 2013;16(2):176-82.
4. Livingston J. Next generation child neurologists. 
Developmental Medicine & Child Neurology. 
2015;57(1):4-5.
5. Kuperberg M, Lev D, Blumkin L, Zerem A, 
Ginsberg M, Linder I, et al. Utility of whole 
exome sequencing for genetic diagnosis of 
previously undiagnosed pediatric neurology 
patients. Journal of child neurology. 
2016;31(14):1534-9.
6. Srivastava S, Cohen JS, Vernon H, Barañano 
K, McClellan R, Jamal L, et al. Clinical whole 
exome sequencing in child neurology practice. 
Annals of neurology. 2014;76(4):473-83.
7. Dixon-Salazar TJ, Silhavy JL, Udpa N, et al. 
Exome sequencing can improve diagnosis and 
alter patient management. Sci Transl Med. 
2012;4(138):138ra78.
8. Liberski PP, Blackstone C. Hereditary 
Spastic Paraplegia. Neurodegeneration. 
2017:161. 
9. Rehman AU, Najafi M, Kambouris M, Al‐Gazali 
L, Makrythanasis P, Rad A, et al. Biallelic 
loss of function variants in PPP1R21 cause a 
neurodevelopmental syndrome with impaired 
endocytic function. Human mutation. 2018.
10. Castro-Gago M, Dacruz-Alvarez D, Pintos-
Martínez E, Beiras-Iglesias A, Arenas J, 
Martín MÁ, et al. Congenital neurogenic 
muscular atrophy in megaconial myopathy 
due to a mutation in CHKB gene. Brain and 
Development. 2016;38(1):167-72.
11. Stessman HA, Xiong B, Coe BP, Wang T, 
Hoekzema K, Fenckova M, et al. Targeted 
sequencing identifies 91 neurodevelopmental-
disorder risk genes with autism and 
developmental-disability biases. Nature 
genetics. 2017;49(4):515.
12. Monies D, Abouelhoda M, AlSayed M, 
Alhassnan Z, Alotaibi M, Kayyali H, et al. The 
landscape of genetic diseases in Saudi Arabia 
based on the first 1000 diagnostic panels and 
exomes. Human genetics. 2017;136(8):921-39.
13. Atwal PS, Brennan M-L, Cox R, Niaki M, Platt 
J, Homeyer M, et al. Clinical whole-exome 
sequencing: are we there yet? Genetics in 
Medicine. 2014;16(9):717-9.
14. Yang Y, Muzny DM, Reid JG, et al. Clinical 
whole-exome sequencing for the diagnosis 
of Mendelian disorders. N Engl J Med 2013; 
369:1502–1511.
15. Landrum MJ, Lee JM, Benson M, Brown 
GR, Chao C, Chitipiralla S, et al. ClinVar: 
improving access to variant interpretations and 
supporting evidence. Nucleic acids research. 
2017;46(D1):D1062-D7.
16. Bond J, Scott S, Hampshire DJ, Springell 
31
The Results of Whole Exome Sequencing Performed On Previously Undiagnosed Pediatric Neurology Patients
Iran J Child Neurol. Spring 2021 Vol. 15 No. 2
K, Corry P, Abramowicz MJ, et al. Protein-
truncating mutations in ASPM cause variable 
reduction in brain size. The American Journal 
of Human Genetics. 2003;73(5):1170-7.
17. Muhammad F, Mahmood Baig S, Hansen L, 
Sajid Hussain M, Anjum Inayat I, Aslam M, et 
al. Compound heterozygous ASPM mutations 
in Pakistani MCPH families. American journal 
of medical genetics Part A. 2009;149(5):926-
30. 
18. Ng SB, Turner EH, Robertson PD, Flygare 
SD, Bigham AW, Lee C, et al. Targeted capture 
and massively parallel sequencing of 12 human 
exomes. Nature. 2009;461(7261):272-6.
19. De Ligt J, Willemsen MH, Van Bon BW, 
Kleefstra T, Yntema HG, Kroes T, et al. 
Diagnostic exome sequencing in persons with 
severe intellectual disability. New England 
Journal of Medicine. 2012;367(20):1921-9.
20. Ng SB, Buckingham KJ, Lee C, Bigham AW, 
Tabor HK, Dent KM, et al. Exome sequencing 
identifies the cause of a mendelian disorder. 
Nature genetics. 2010;42(1):30-5.
